Design and use of an inducibly activated human immunodeficiency virus type 1 Nef to study immune modulation

Journal of Virology

Volumn 75, Issue 2, 2001, Pages 834-843

  Walk, S F ^a   Alexander, M ^a   Maier, B ^a   Hammarskjold, M L ^a   Rekosh, D M ^a   Ravichandran, K S ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; CD4 ANTIGEN; ESTROGEN RECEPTOR; HLA A2 ANTIGEN; NEF PROTEIN; PROTEIN SERINE THREONINE KINASE;

ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOMODULATION; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSACTIVATION;

ANIMALS; ANTIGENS, CD4; CELL LINE; DOWN-REGULATION; GENE PRODUCTS, NEF; HIV-1; HLA-A2 ANTIGEN; HUMANS; MEMBRANE MICRODOMAINS; MICE; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, ESTROGEN; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES; TAMOXIFEN; TRANSFECTION;

EID: 0035172438     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.2.834-843.2001     Document Type: Article

References (68)

1. Nef induces CD4 endocytosis: Requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain
2. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis
3. 2+ flux
4. The N-terminus of Nef from HIV-1/SIV associates with a protein complex containing Lck and a serine kinase
5. HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization
6. Activation of the PAK-related kinase by human immunodeficiency virus type 1 Nef in primary human peripheral blood lymphocytes and macrophages leads to phosphorylation of a PIX-p95 complex
7. Functions of lipid rafts in biological membranes
8. Simian immunodeficiency virus containing mutations in N-terminal tyrosine residues and in the PxxP motif in Nef replicates efficiently in rhesus macaques
9. SHIP inhibits Akt activation in B cells through regulation of Akt membrane localization
10. Molecular switches in lipid rafts
11. Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene
12. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells
13. HIV's evasion of the cellular immune response
14. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes
15. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients
16. p21-activated kinase 1 plays a critical role in cellular activation by Nef
17. Serine phosphorylation-independent downregulation of cell-surface CD4 by nef
18. A dileucine motif in HIV-1 Nef is essential for sorting into clathrin-coated pits and for downregulation of CD4
19. The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes
20. HIV F/3′ off encodes a phosphorylated GTP-binding protein resembling an oncogene product
21. Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice
22. The role of myristoylation in the interactions between human immunodeficiency virus type I Nef and cellular proteins
23. Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling
24. Aggregation of lipid rafts accompanies signaling via the T cell antigen receptor
25. The role of lipid rafts in T cell antigen receptor (TCR) signalling
26. Genetic characterization of human immunodeficiency virus type 1 nef gene products translated in vitro and expressed in mammalian cells
27. Importance of the nef gene for maintenance of high virus loads and for development of AIDS
28. Sequence variations in human immunodeficiency virus type 1 Nef are associated with different stages of disease
29. Brief report: Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection
30. Activation of phosphatidylinositol 3-kinase is sufficient for cell cycle entry and promotes cellular changes characteristic of oncogenic transformation
31. Construction and characterization of a conditionally active version of the serine/threonine kinase Akt
32. Shc interaction with Src homology 2 domain containing inositol phosphatase (SHIP) in vivo requires the Shc-phosphotyrosine binding domain and two specific phosphotyrosines on SHIP
33. Association of simian immunodeficiency virus Nef with cellular serine/threonine kinases is dispensable for the development of AIDS in rhesus macaques
34. Membrane rafts and signaling by the multichain immune recognition receptors
35. Distinct trafficking pathways mediate Nef-induced and clathrin-dependent major histocompatibility complex class I down-regulation
36. Human immunodeficiency virus type I Nef independently affects virion incorporation of major histocompatibility complex class I molecules and virus infectivity
37. Localization of LAT in glycolipid-enriched microdomains is required for T cell activation
38. Human immune response to HIV-1-Nef. I. CD45RO- T lymphocytes of non-infected donors contain cytotoxic T lymphocyte precursors at high frequency
39. Synergistic activation of NFAT by HIV-1 nef and the Ras/MAPK pathway
40. SH3-domain binding function of HIV-1 Nef is required for association with a PAK-related kinase
41. CD4 down-regulation by nef alleles isolated from human immunodeficiency virus type 1-infected individuals
42. The numerous effector functions of Nef
43. The human immunodeficiency virus-1 nef gene product: A positive factor for viral infection and replication in primary lymphocytes and macrophages
44. Human immunodeficiency virus type 1 Nef associates with a member of the p21-activated kinase family
45. HIV nef: The mother of all evil?
46. Nef-induced CD4 degradation: A diacidic-based motif in Nef functions as a lysosomal targeting signal through the binding of beta-COP in endosomes
47. The downregulation of CD4 and MHC-I by primate lentiviruses: A paradigm for the modulation of cell surface receptors
48. The Nef protein of primate lentiviruses
49. HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histocompatibility complexes
50. Conditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in NIH 3T3 cells
51. Evidence for a requirement for both phospholipid and phosphotyrosine binding via the Shc phosphotyrosine-binding domain in vivo
52. Identification of the Nef-associated kinase as p21-activated kinase 2
53. Interactions of HIV-1 NEF with cellular signal transducing proteins
54. The dileucine-based sorting motif in HIV-1 Nef is not required for down-regulation of class I MHC
55. HIV-1 Nef and host cell protein kinases
56. Nef proteins of the human immunodeficiency viruses (HIV-1 and HIV-2) and simian immunodeficiency virus (SIV) are structurally similar to leucine zipper transcriptional activation factors
57. Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes
58. Activation of PAK by HIV and SIV Nef: Importance for AIDS in rhesus macaques
59. HIV-1 Nef increases T cell activation in a stimulus-dependent manner
60. Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell
61. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein
62. Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo
63. The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes
64. Polyunsaturated fatty acids inhibit T cell signal transduction by modification of detergent-insoluble membrane domains
65. The Nef protein of HIV-1 associates with rafts and primes T cells for activation
66. Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain
67. Effect of myristoylation on p27 nef subcellular distribution and suppression of HIV-LTR transcription
68. LAT palmitoylation: Its essential role in membrane microdomain targeting and tyrosine phosphorylation during T cell activation